Rinosedin 0,1 %, Nasenspray, Lösung - 10 ml Swissmedic Key 53348017 Registration Holder Streuli Pharma AG Name Rinosedin 0,1 %, Nasenspray, Lösung Date of registration 04.07.1996 Introduction of Sequence 04.07.1996 ATC-Classification Xylometazoline (R01AA07) Revision date 11.07.2007 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 12.02.10. Show package size 10 ml Index Therapeuticus (Swissmedic) 12.02.10. Description Swissmedic categorie. D SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 1.98 Limitation No Deductible 10 % Consumer price 3.65 Feedback FB GTIN 7680533480178 Medication Code Synthetika Pharmacode 1755657 Disponibility ●
Composition xylometazolini hydrochloridum 1.000 mg corresp. xylometazolini hydrochloridum 0.09 mg pro dosi, benzalkonii chloridum 0.125 mg, dinatrii phosphas, natrii dihydrogenophosphas dihydricus, aqua purificata ad solutionem pro 1 ml, doses pro vase 111. Packungsbestandteile Galenic Form Nasal spray Excipiens Active Agent Dose Xylometazoline Hydrochloride 1 mg/ml correspond Xylometazoline Hydrochloride 0.09 mg/ml
BAG: Active Agent Dose Xylometazoline Hydrochloride 1 mg
Inactive agents Dose Aqua Purificata Benzalkonium Chloride 0.125 mg/ml Disodium Phosphate Sodium Dihydrogenophosphate Dihydrate
Source Data was imported : 12.03.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
